368 related articles for article (PubMed ID: 38650942)
1. Immune modulation in transplant medicine: a comprehensive review of cell therapy applications and future directions.
Knoedler L; Dean J; Diatta F; Thompson N; Knoedler S; Rhys R; Sherwani K; Ettl T; Mayer S; Falkner F; Kilian K; Panayi AC; Iske J; Safi AF; Tullius SG; Haykal S; Pomahac B; Kauke-Navarro M
Front Immunol; 2024; 15():1372862. PubMed ID: 38650942
[TBL] [Abstract][Full Text] [Related]
2. Novel Strategies in Transplantation: Genetic Engineering and Vascularized Composite Allotransplantation.
Kauke-Navarro M; Noel OF; Knoedler L; Knoedler S; Panayi AC; Stoegner VA; Huelsboemer L; Pomahac B
J Surg Res; 2023 Nov; 291():176-186. PubMed ID: 37429217
[TBL] [Abstract][Full Text] [Related]
3. Vascularized composite allografts and solid organ transplants: similarities and differences.
Weissenbacher A; Hautz T; Pratschke J; Schneeberger S
Curr Opin Organ Transplant; 2013 Dec; 18(6):640-4. PubMed ID: 24126807
[TBL] [Abstract][Full Text] [Related]
4. Novel cell-based strategies for immunomodulation in vascularized composite allotransplantation.
Siemionow M; Kulahci Y; Zor F
Curr Opin Organ Transplant; 2023 Dec; 28(6):431-439. PubMed ID: 37800652
[TBL] [Abstract][Full Text] [Related]
5. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
Johnstone BH; Messner F; Brandacher G; Woods EJ
Front Immunol; 2021; 12():622604. PubMed ID: 33732244
[TBL] [Abstract][Full Text] [Related]
6. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.
Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG
Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179
[TBL] [Abstract][Full Text] [Related]
7. Cell therapy in transplantation: A comprehensive review of the current applications of cell therapy in transplant patients with the focus on Tregs, CAR Tregs, and Mesenchymal stem cells.
Mansourabadi AH; Mohamed Khosroshahi L; Noorbakhsh F; Amirzargar A
Int Immunopharmacol; 2021 Aug; 97():107669. PubMed ID: 33965760
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells as immunomodulators in a vascularized composite allotransplantation.
Kuo YR; Chen CC; Goto S; Lin PY; Wei FC; Chen CL
Clin Dev Immunol; 2012; 2012():854846. PubMed ID: 23227090
[TBL] [Abstract][Full Text] [Related]
9. Large Animal Models of Vascularized Composite Allotransplantation: A Review of Immune Strategies to Improve Allograft Outcomes.
Matar AJ; Crepeau RL; Mundinger GS; Cetrulo CL; Torabi R
Front Immunol; 2021; 12():664577. PubMed ID: 34276656
[TBL] [Abstract][Full Text] [Related]
10. Adoptive Transfer of Regulatory Immune Cells in Organ Transplantation.
Oberholtzer N; Atkinson C; Nadig SN
Front Immunol; 2021; 12():631365. PubMed ID: 33737934
[TBL] [Abstract][Full Text] [Related]
11. Vascularized composite allotransplantation versus solid organ transplantation: innate-adaptive immune interphase.
Kadono K; Gruszynski M; Azari K; Kupiec-Weglinski JW
Curr Opin Organ Transplant; 2019 Dec; 24(6):714-720. PubMed ID: 31577596
[TBL] [Abstract][Full Text] [Related]
12. Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite allotransplantation.
Schweizer R; Gorantla VS; Plock JA
Curr Opin Organ Transplant; 2015 Dec; 20(6):608-14. PubMed ID: 26536421
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells induce transplant immune tolerance.
Lu J; Li P; Du X; Liu Y; Zhang B; Qi F
Transpl Immunol; 2021 Aug; 67():101411. PubMed ID: 34020045
[TBL] [Abstract][Full Text] [Related]
14. Vascularised composite allotransplantation in solid organ transplant recipients: A systematic review.
Honeyman C; Stark HL; Fries CA; Gorantla VS; Davis MR; Giele H
J Plast Reconstr Aesthet Surg; 2021 Feb; 74(2):316-326. PubMed ID: 33036926
[TBL] [Abstract][Full Text] [Related]
15. Monitoring and long-term outcomes in vascularized composite allotransplantation.
Kaufman CL; Ouseph R; Marvin MR; Manon-Matos Y; Blair B; Kutz JE
Curr Opin Organ Transplant; 2013 Dec; 18(6):652-8. PubMed ID: 24220047
[TBL] [Abstract][Full Text] [Related]
16. The impact of mesenchymal stem cell therapy in transplant rejection and tolerance.
Franquesa M; Hoogduijn MJ; Baan CC
Curr Opin Organ Transplant; 2012 Aug; 17(4):355-61. PubMed ID: 22710385
[TBL] [Abstract][Full Text] [Related]
17. CD4
Jeyamogan S; Leventhal JR; Mathew JM; Zhang ZJ
Front Immunol; 2023; 14():1270300. PubMed ID: 37868962
[TBL] [Abstract][Full Text] [Related]
18. Adipose-derived cellular therapies in solid organ and vascularized-composite allotransplantation.
Stivers KB; Beare JE; Chilton PM; Williams SK; Kaufman CL; Hoying JB
Curr Opin Organ Transplant; 2017 Oct; 22(5):490-498. PubMed ID: 28873074
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T Cells: Liquid and Living Precision Medicine for the Future of VCA.
Kauke-Navarro M; Knoedler S; Panayi AC; Knoedler L; Noel OF; Pomahac B
Transplantation; 2023 Jan; 107(1):86-97. PubMed ID: 36210500
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous resolution of acute rejection and tolerance induction with IL-2 fusion protein in vascularized composite allotransplantation.
Jindal R; Unadkat J; Zhang W; Zhang D; Ng TW; Wang Y; Jiang J; Lakkis F; Rubin P; Lee WP; Gorantla VS; Zheng XX
Am J Transplant; 2015 May; 15(5):1231-40. PubMed ID: 25676865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
